Board ReviewPediatricsAlgorithm

DiGeorge Syndrome Algorithm for the Pediatrics Shelf: 22q11.2 Deletion Step by Step

Work up 22q11.2 deletion step by step for the pediatrics shelf: neonatal hypocalcemia, conotruncal defects, T cells, irradiated blood and microarray.

Contents
  1. The algorithm
  2. Clue in the stem, next best step
  3. Where students lose points
  4. Practice question
  5. 60-second recall
  6. Sources

On the pediatrics shelf, 22q11.2 deletion shows up as a newborn or young infant with a conotruncal heart defect and one more clue: jitteriness or a seizure from low calcium, a small or absent thymus, frequent infections, a palate problem or a characteristic face. The question tests whether you link the heart to the calcium and the T cells, then pick the safe next step.

The algorithm

Steps 1 to 3 handle the sick newborn; steps 4 to 9 are the workup every child with a suspected deletion needs.

  1. Spot the patternThe classic triad is a conotruncal heart defect, hypocalcemia from hypoparathyroidism and T-cell deficiency from thymic hypoplasia; palate problems and typical facial features are the other two major findings. Congenital heart disease is present in about 64% of people with the deletion, hypocalcemia in about half. GeneReviews lists each of these findings as a reason to suspect the deletion.
  2. Jittery or seizing newborn: check glucose and calcium firstIn a term infant, a total calcium below 8 mg/dL is hypocalcemia; ionized cutoffs depend on the analyzer, roughly 3.0 to 4.4 mg/dL. Symptoms such as jitteriness, tetany, apnea and seizures are rare unless total calcium is below 7 mg/dL or ionized calcium below 3.0 mg/dL. A long QTc supports it. A normal glucose rules out hypoglycemia, and a normal CSF makes infection less likely.
  3. Symptomatic: give IV calcium nowGive 10% calcium gluconate by slow IV infusion over about 30 minutes while watching the heart rate. A fast infusion can cause bradycardia, and leaking into the tissue can cause necrosis. Treatment does not wait for the genetic result.
  4. Prove the parathyroids are the causeSend intact PTH with an ionized calcium, plus magnesium and phosphorus. Low calcium with a low PTH is hypoparathyroidism. With a conotruncal defect, that points to 22q11.2 deletion: the thymus (third pouch) and parathyroids (third and fourth pouches) share a pharyngeal origin. Hypocalcemia often settles with age but can return with illness, puberty and pregnancy, so ionized calcium is checked before and after any surgery.
  5. Image the heartGet an echocardiogram, ECG and chest x-ray. The most common lesions are VSD (23%), tetralogy of Fallot (18%), aortic arch anomalies (14%) and interrupted aortic arch (11%); truncus arteriosus is 4%. Many centers send early genetic testing in newborns with conotruncal defects, especially tetralogy, truncus and an interrupted arch.
  6. Count the T cells before any transfusion or surgeryOrder a CBC with differential and flow cytometry for T-cell subsets, including naive T cells. Until T-cell immunity is shown to be adequate, give only irradiated blood products to prevent transfusion-associated graft-versus-host disease. If there is no time to test before surgery, irradiate anyway. Live vaccines (rotavirus, MMR, varicella) wait until the T-cell numbers qualify; inactivated vaccines stay on schedule.
  7. Rule out congenital athymiaFewer than 1% of children with the deletion have no thymic function: naive T cells below 50 per mm3 and a SCID-like risk of severe infection. This is an immunologic emergency. Start protective isolation, use blood that is irradiated, leukocyte-reduced and CMV-negative, give Pneumocystis prophylaxis, and refer for thymus tissue implantation, FDA-approved in the US since 2021.
  8. Confirm with chromosomal microarrayMicroarray detects the deletion; about 85% of patients carry the same 2.5 Mb deletion. A standard karyotype cannot see it, and commercial FISH probes miss atypical deletions that lie outside the probe region, so FISH is mainly for testing relatives of a known patient.
  9. Screen the rest of the body and the familyAt diagnosis check TSH and free T4, order a renal ultrasound (kidney anomalies in about 16%), and arrange palate, hearing, eye, feeding and developmental assessments. About 67% have a palatal abnormality, most often velopharyngeal insufficiency. Test both parents: more than 90% of typical deletions are new, but an affected parent passes it to each child with a 50% chance. Plan psychiatric follow-up, since about 25% of adults develop schizophrenia.

Many textbooks still use DiGeorge syndrome as a synonym; GeneReviews (2025) now reserves that name for the same clinical picture without a detected 22q11.2 deletion.

Clue in the stem, next best step

Clue in the stemWhat it points toNext best step
Day-3 term infant with tetralogy of Fallot and jittery episodesHypocalcemia from hypoparathyroidismGlucose, ionized calcium, PTH and magnesium
Newborn seizure, glucose and CSF normal, total calcium 6.4 mg/dLSymptomatic hypocalcemiaSlow IV 10% calcium gluconate with heart-rate monitoring
Newborn with an interrupted aortic arch or truncus arteriosusConotruncal defect linked to 22q11.2 deletionChromosomal microarray, calcium and T-cell subsets
Low absolute lymphocyte count in an infant with the deletionThymic hypoplasia with T-cell deficiencyFlow cytometry for T-cell subsets and naive T cells; immunology referral
Infant with the deletion needs blood before T cells are measuredRisk of transfusion-associated graft-versus-host diseaseIrradiated blood products
Naive T cells under 50 per mm3, severe or unusual infectionsCongenital athymiaIsolation, irradiated leukocyte-reduced CMV-negative blood, Pneumocystis prophylaxis, thymus tissue implantation
12-month-old with the deletion due for MMR and varicellaLive vaccine safetyCheck CD4, CD8, tetanus IgG and naive T cells first
Toddler with hypernasal speech and milk coming out of the noseVelopharyngeal insufficiency or submucous cleftPalate and speech evaluation with the cleft team
Picture fits, but the karyotype was normalA karyotype cannot detect the deletionChromosomal microarray

Where students lose points

  • Working up only infection in a seizing newborn with a heart defect. Check calcium first; the heart defect is the clue.
  • Choosing a karyotype to confirm the diagnosis. A standard karyotype cannot see the deletion; chromosomal microarray can.
  • Transfusing standard blood because the surgery is urgent. If T-cell status is unknown, the answer is irradiated products, red cells and platelets alike.
  • Getting the vaccines wrong in either direction. Live vaccines wait for adequate T-cell numbers, but inactivated vaccines go on schedule.
  • Treating hypocalcemia as a one-time newborn problem. It can come back with illness, puberty and pregnancy, and ionized calcium is checked around every operation.
  • Skipping parental testing because most deletions are new. Only testing the parents shows the true recurrence risk.

Practice question

A 6-week-old boy with tetralogy of Fallot is admitted for complete surgical repair tomorrow. On day 3 of life he had jittery episodes with a total calcium of 6.8 mg/dL that resolved with IV calcium gluconate, and chromosomal microarray later showed a 22q11.2 deletion. He now takes oral calcium. Temperature is 37.0 C, pulse 152/min, respirations 46/min and oxygen saturation 86% on room air. Hemoglobin is 17.2 g/dL, platelets 210,000/mm3, absolute lymphocyte count 1,400/mm3 and ionized calcium 4.6 mg/dL. Flow cytometry for T-cell subsets was sent this morning; results will take 3 days. The surgeons expect to give red cells and platelets during bypass.

Which of the following is the most appropriate plan for blood products?

  1. Standard red cells and platelets with no special processing
  2. Irradiated red cells and platelets
  3. IV immune globulin before standard red cells and platelets
  4. Postpone the repair until thymus tissue implantation
  5. Irradiated red cells only, with standard platelets
Show the answer

Answer: B. His T-cell status is unknown and surgery cannot wait for the result. GeneReviews advises irradiated blood products until immune function is confirmed normal, and the immunology guideline recommends irradiation whenever a T-cell deficiency is possible but cannot be measured before surgery. Irradiation prevents transfusion-associated graft-versus-host disease.

Why the others are wrong. A: non-irradiated products risk graft-versus-host disease in an infant who may lack T cells. C: immune globulin replaces antibodies and does nothing to prevent graft-versus-host disease. D: thymus implantation is for congenital athymia, found in fewer than 1% of patients and not shown here, and his cyanosis needs the repair. E: the guidance covers platelets as well as red cells.

60-second recall

Say each answer out loud before you reveal it, then mark yourself. Retrieval, not rereading, is what makes it stick.

  1. 1Classic 22q11.2 deletion triad
    Conotruncal heart defect, hypocalcemia from hypoparathyroidism, T-cell deficiency from thymic hypoplasia.
    Did you get it?
  2. 2Test that confirms the deletion
    Chromosomal microarray (a standard karyotype cannot see it).
    Did you get it?
  3. 3Blood products before T-cell immunity is confirmed
    Irradiated, to prevent transfusion-associated graft-versus-host disease.
    Did you get it?
  4. 4Live vaccine criteria at 12 months
    CD4 at least 400/mm3, CD8 at least 200/mm3, protective tetanus IgG, mostly naive T cells.
    Did you get it?
  5. 5Congenital athymia
    Naive T cells below 50/mm3; isolation, irradiated CMV-negative blood and thymus tissue implantation.
    Did you get it?

Next: browse every Board Review post, work through the neonatal jaundice algorithm, present a pediatrics case with MedRise Viva, or see MedRise for students. Test yourself with today's Daily Case on Instagram @medrise_ at 7:30 PM Central, and hear it worked through on the MedRise Podcast.

Sources

  1. McDonald-McGinn DM, Hain HS, Emanuel BS, Zackai EH. 22q11.2 deletion syndrome. GeneReviews (NCBI Bookshelf), last revised 2025
  2. Mustillo PJ, et al. Clinical practice guidelines for the immunological management of chromosome 22q11.2 deletion syndrome and other defects in thymic development. J Clin Immunol, 2023 (PubMed)
  3. Dysart KC. Neonatal hypocalcemia. MSD Manual Professional Edition, reviewed 2024, updated 2026

MedRise Board Review is educational content for exam preparation only. It is not medical advice and does not replace current guidelines, your school's materials or clinical judgment.

Learned something the hard way on a shelf or on the wards?

Write it up for MedRise Perspectives: 600 to 1,200 words, published under your name, with a decision usually within one day.

Book a free strategy call

Ten minutes to look at your exam date, your scores and what is getting in the way.